Skip to content

Cataract Surgery on Advanced Age Related Macular Degeneration Patients

The Effects of Unilateral and Bilateral Cataract Extraction on Visual Function of Advanced Age-Related Macular Degeneration Patients.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04045704
Enrollment
0
Registered
2019-08-05
Start date
2019-10-31
Completion date
2019-12-31
Last updated
2021-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Macular Degeneration Advanced

Brief summary

The degree at which cataract surgery improves visual function in patients with advanced age-related macular degeneration (Advanced AMD) has been an on-going topic of discussion. Our objective in this study is to determine if patients with Advanced AMD and concurrent cataracts will experience greater improvement in their quality of life from having cataract surgery on one or both eyes. The findings from this project will provide evidence for clinical decision making on whether performing bilateral cataract surgery on Advanced AMD patients is cost-effective and worth the second surgical intervention.

Interventions

PROCEDURECataract Surgery

Patients with bilateral Advanced Age-related macular degeneration and concurrent cataracts will be receiving bilateral cataract surgery

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients above the age of fifty with both Advanced AMD and Cataracts bilaterally from the Okanagan Valley will be selected for this study. Patients who chose to have bilateral cataract surgery, were able to understand the research parameters, and had no other severe eye disease that may distort the studies results. Patients will be selected for the study according to the National Eye Institute definition of Advanced AMD. Advanced AMD (AREDS category 4) is characterized by one or more of the following (in the absence of other causes) in one eye: Geographic atrophy of the RPE involving the foveal center. Neovascular maculopathy that includes the following: * Choroidal neovascularization (CNV) defined as pathologic angiogenesis originating from the choroidal vasculature that extends through a defect in Bruch's membrane * Serous and/or hemorrhagic detachment of the neurosensory retina or RPE * Retinal hard exudates (a secondary phenomenon resulting from chronic intravascular leakage) * Subretinal and sub-RPE fibrovascular proliferation * Disciform scar (subretinal fibrosis)

Exclusion criteria

* Severe intraoperative or postoperative complications such as retinal detachments, and capsule ruptures * Inability to complete the required testing (auto-refractive and visual acuity) * Inability to attend appointments * Inability to complete the questionnaire with Co-I assistance * Severe eye disease that may distort the studies results such as but not limited to Epithelial Basement Membrane Dystrophy (EBMD) and retinal detachments.

Design outcomes

Primary

MeasureTime frameDescription
Life style Questionnaire to determine change in visual function.Through study completion, an average of 1 yearOur primary outcome will be a life style questionnaire (qualitative) to determine the change in visual function from baseline to after surgery. This questionnaire includes 25 close-ended questions that are graded on a 5 point grading scale from 1 (great difficulty due to vision) and 5 (no problem due to vision). The questions can also be graded as not applicable to an individuals life, or 0 being something there are no longer possible to do, due to vision. The 25 close-ended questions are divided into 4 sub-scales: 1. Distance Vision, Mobility, and Lighting (Q: 1-12) 2. Adjustment (Q:13-16) 3. Reading and Fine Work (Q: 17-21) 4. Activities of Daily Living (Q: 22-25) A total score can range from a 125 indicating best visual function to 0 indicating complete loss of visual function.

Secondary

MeasureTime frameDescription
Snellens Chart to determine change in visual acuityThrough study completion, an average of 1 yearQuantitative measure of a patients visual acuity. Change from baseline visual acuity to after surgery on both eyes.
Auto Refractive to determine change in visual acuityThrough study completion, an average of 1 yearAn auto-refractor is a computerized machine to measure patients visual acuity. Change from baseline visual acuity to after surgery on both eyes.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026